Biotechnology Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community October 9, 2020
Biotechnology Apellis to Present Positive Results from the Phase 2 DISCOVERY Study of Pegcetacoplan in C3 Glomerulopathy (C3G) at ASN Kidney Week October 9, 2020
Biotechnology STOCKHOLDER ALERT: Monteverde & Associates Reminds Investors of its Ongoing Investigation Regarding the Merger October 9, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - BMRN October 8, 2020